| KASL clinical practice guidelines: management of nonalcoholic fatty liver disease SH Kang, HW Lee, JJ Yoo, Y Cho, SU Kim, TH Lee, BK Jang, SG Kim, ... Clinical and molecular hepatology 27 (3), 363, 2021 | 195 | 2021 |
| Serum tumor markers provide refined prognostication in selecting liver transplantation candidate for hepatocellular carcinoma patients beyond the Milan criteria JH Lee, Y Cho, HY Kim, EJ Cho, DH Lee, SJ Yu, JW Lee, NJ Yi, KW Lee, ... Annals of surgery 263 (5), 842-850, 2016 | 132 | 2016 |
| Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment M Lee, GE Chung, JH Lee, S Oh, JY Nam, Y Chang, H Cho, H Ahn, ... Hepatology 66 (5), 1556-1569, 2017 | 112 | 2017 |
| CLIF‐SOFA scoring system accurately predicts short‐term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis M Lee, JH Lee, S Oh, Y Jang, W Lee, HJ Lee, J Yoo, WM Choi, YY Cho, ... Liver International 35 (1), 46-57, 2015 | 93 | 2015 |
| Ten‐day sequential therapy is more effective than proton pump inhibitor‐based therapy in Korea: A prospective, randomized study HS Oh, DH Lee, JY Seo, YR Cho, N Kim, SH Jeoung, JW Kim, JH Hwang, ... Journal of gastroenterology and hepatology 27 (3), 504-509, 2012 | 85 | 2012 |
| From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple? SH Kang, Y Cho, SW Jeong, SU Kim, JW Lee, ... Clinical and molecular hepatology 27 (2), 257, 2021 | 81 | 2021 |
| Heterochiral assembly of amphiphilic peptides inside the mitochondria for supramolecular cancer therapeutics MT Jeena, K Jeong, EM Go, Y Cho, S Lee, S Jin, SW Hwang, JH Jang, ... ACS nano 13 (10), 11022-11033, 2019 | 70 | 2019 |
| High titers of anti‐HBs prevent rituximab‐related viral reactivation in resolved hepatitis B patient with non‐Hodgkin's lymphoma Y Cho, SJ Yu, EJ Cho, JH Lee, TM Kim, DS Heo, YJ Kim, JH Yoon Journal of medical virology 88 (6), 1010-1017, 2016 | 65 | 2016 |
| Does 18F-FDG Positron Emission Tomography-Computed Tomography Have a Role in Initial Staging of Hepatocellular Carcinoma? Y Cho, DH Lee, YB Lee, M Lee, J Yoo, W Choi, YY Cho, JC Paeng, ... PLoS One 9 (8), e105679, 2014 | 61 | 2014 |
| Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly JA Kang, S Kim, M Park, HJ Park, JH Kim, S Park, JR Hwang, YC Kim, ... Nature communications 10 (1), 2184, 2019 | 56 | 2019 |
| In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic … S Kim, SA Kim, GH Nam, Y Hong, GB Kim, Y Choi, S Lee, Y Cho, M Kwon, ... Journal for ImmunoTherapy of Cancer 9 (1), 2021 | 47 | 2021 |
| Modified AS1411 aptamer suppresses hepatocellular carcinoma by up-regulating galectin-14 Y Cho, YB Lee, JH Lee, DH Lee, EJ Cho, SJ Yu, YJ Kim, JI Kim, JH Im, ... PloS one 11 (8), e0160822, 2016 | 47 | 2016 |
| Novel model to predict HCC recurrence after liver transplantation obtained using deep learning: a multicenter study JY Nam, JH Lee, J Bae, Y Chang, Y Cho, DH Sinn, BH Kim, SH Kim, NJ Yi, ... Cancers 12 (10), 2791, 2020 | 46 | 2020 |
| Fucoidan protects hepatocytes from apoptosis and inhibits invasion of hepatocellular carcinoma by up-regulating p42/44 MAPK-dependent NDRG-1/CAP43 Y Cho, JH Yoon, J Yoo, M Lee, DH Lee, EJ Cho, JH Lee, SJ Yu, YJ Kim, ... Acta Pharmaceutica Sinica B 5 (6), 544-553, 2015 | 44 | 2015 |
| Hydrochemical assessment of environmental status of surface and ground water in mine areas in South Korea: emphasis on geochemical behaviors of metals and sulfate in ground water DM Kim, ST Yun, Y Cho, JH Hong, B Batsaikhan, J Oh Journal of Geochemical Exploration 183, 33-45, 2017 | 42 | 2017 |
| Efficacy of entecavir-tenofovir combination therapy for chronic hepatitis B patients with multidrug-resistant strains YB Lee, JH Lee, DH Lee, H Cho, H Ahn, WM Choi, YY Cho, M Lee, ... Antimicrobial Agents and Chemotherapy 58 (11), 6710-6716, 2014 | 42 | 2014 |
| Prior exposure to lamivudine increases entecavir resistance risk in chronic hepatitis B Patients without detectable lamivudine resistance JH Lee, Y Cho, DH Lee, M Lee, J Yoo, W Choi, YY Cho, YB Lee, SJ Yu, ... Antimicrobial agents and chemotherapy 58 (3), 1730-1737, 2014 | 42 | 2014 |
| Entecavir and tenofovir reduce hepatitis B virus‐related hepatocellular carcinoma recurrence more effectively than other antivirals H Cho, H Ahn, DH Lee, JH Lee, YJ Jung, Y Chang, JY Nam, YY Cho, ... Journal of viral hepatitis 25 (6), 707-717, 2018 | 41 | 2018 |
| Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus SW Kim, JS Yoon, M Lee, Y Cho Clinical and molecular hepatology 28 (1), 17, 2022 | 40 | 2022 |
| Survival analysis of single large (> 5 cm) hepatocellular carcinoma patients: BCLC A versus B Y Cho, DH Sinn, SJ Yu, GY Gwak, JH Kim, YJ Yoo, DW Jun, TY Kim, ... PloS one 11 (11), e0165722, 2016 | 39 | 2016 |
Su Jong YuSeoul National University Hospital在 snu.ac.kr 的电子邮件经过验证
